Meibomian Gland Dysfunction: Poor Evidence for Oral Antibiotics Meibomian Gland Dysfunction: Poor Evidence for Oral Antibiotics
More research is needed to define the role of doxycycline, minocycline, and azithromycin in this difficult-to-treat condition. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 29, 2015 Category: Consumer Health News Tags: Ophthalmology News Source Type: news
Doxycycline Barely Beats Azithromycin for Chlamydia Doxycycline Barely Beats Azithromycin for Chlamydia
Although azithromycin failed a noninferiority comparison with doxycycline, the greater difficulty of treatment adherence for the latter drug may make the findings moot, experts suggest. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 24, 2015 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
DOJ antitrust unit subpoenas Mylan over pricing of doxycycline
(Reuters) - The antitrust division of the U.S. Department of Justice has subpoenaed Mylan N.V. for information relating to the pricing and marketing of its generic doxycycline antibiotic products, the drugmaker said on Friday. (Source: Reuters: Health)
Source: Reuters: Health - December 4, 2015 Category: Consumer Health News Tags: healthNews Source Type: news
PolyPid Announces Issuance Of New U.S. Patent For Doxycycline Sustained Release Compositions
PolyPid, a clinical stage pharmaceutical company and developer of PLEX, a protected drug reservoir platform for effective localized, controlled and prolonged drug delivery, recently announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 9,173,976, covering compositions for sustained and/or controlled release of doxycycline. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 20, 2015 Category: Pharmaceuticals Source Type: news
Is Lyme the New AIDS? Part Three: A Caution to Gay Men
Note: This is the third and final entry in a series about how my life has been devastated by Lyme disease. With the advent of PrEP and effective medical interventions for HIV, I am truly disturbed that gay men -- first, younger generations, but increasingly people my age who lived through the plague of AIDS -- increasingly are rejecting the use of condoms and feeling invulnerable to potential sexually transmitted infections. Although the CDC claims absolutely that Lyme disease cannot be transmitted sexually, objective scientific research and anecdotes of those whose partners have Lyme argue otherwise. You do not want Ly...
Source: Healthy Living - The Huffington Post - November 10, 2015 Category: Consumer Health News Source Type: news
Answers elusive in quest for better chlamydia treatment
SAN DIEGO – The hottest topic today in the treatment of sexually transmitted diseases caused by Chlamydia trachomatis is the unresolved question of whether azithromycin is still as effective as doxycycline, the other current guideline-recommended, first-line therapy, Dr. Kimberly Workowski... (Source: Skin and Allergy News)
Source: Skin and Allergy News - November 7, 2015 Category: Dermatology Source Type: news
Why many generic drugs are becoming so expensive
The high cost of prescription drugs is big news. You hear about it on television, in your doctor’s office, and even on the campaign trail. When you think about expensive drugs, you may think about novel therapies for lung cancer or hepatitis C. But in fact, prices are also skyrocketing for the generic versions of some commonly prescribed drugs.
An article published last year in The New England Journal of Medicine reported that between 2012 and 2013, captopril — a generic drug used to treat high blood pressure and heart failure — increased in price from 1 cent to 40 cents per pill. During this same period, the cost of...
Source: New Harvard Health Information - October 22, 2015 Category: Consumer Health News Authors: Ameet Sarpatwari, JD, PhD Tags: Drugs and Supplements Health generic drugs generics medications Source Type: news
Turing Pharmaceuticals Did Us One Big Favor
Dear Turing Pharmaceuticals,
Thank you. Thank you for exposing what I have known for years, that health care in the United States is commoditized instead of treated like a human right. By showing the severity of your greed in raising the price of Daraprim from $13.50 to $750 per pill, you captured the ire of the public. However, you've done one good thing for the American public through this incredibly greedy move: You put price gouging of specialty drugs on a national stage.
I've known about this for years because I've been exposed to price gouging in the medical world since I was 16. While most kids were worrying abou...
Source: Healthy Living - The Huffington Post - September 22, 2015 Category: Consumer Health News Source Type: news
Azithromycin noninferior to doxycycline for chlamydia
BRISBANE, AUSTRALIA – Azithromycin has been shown to be noninferior to doxycycline in the treatment of chlamydia, in a randomized clinical trial conducted in a youth correctional facility.
The study, presented at the World STI & HIV Congress 2015, found a 7-day, twice-daily regimen of 100 mg... (Source: Skin and Allergy News)
Source: Skin and Allergy News - September 15, 2015 Category: Dermatology Source Type: news
Topical Cyclosporine Better for Ocular RosaceaTopical Cyclosporine Better for Ocular Rosacea
A new comparative study has found that topical cyclosporine is more effective than oral doxycycline at relieving symptoms and treating eyelid and dry eye signs in patients with ocular rosacea. Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 27, 2015 Category: Dermatology Tags: Ophthalmology News Source Type: news
Ticks can transmit a new Lyme-like disease
There are several good reasons to keep ticks off your body. One is that they are creepy and suck your blood. Another is that they can transmit 14 different diseases—not just Lyme disease. A report published online this week in the journal Annals of Internal Medicine describes the newest tick-borne disease in North America, which is caused by a bacterium known as Borrelia miyamotoi.
The microbe was first identified in Japan in 1995. The first report of it infecting humans came from Russia in 2011. Cases began appearing in the northeastern United States in 2013.
Borrelia miyamotoi is a spiral-shaped bacterium that is relat...
Source: New Harvard Health Information - June 11, 2015 Category: Consumer Health News Authors: Howard LeWine, M.D. Tags: Health Prevention Borrelia miyamotoi Lyme disease ticks Source Type: news
Rat Bite Fever: General Information
Rat bite fever (RBF) is caused by either Spirillum minus or Streptobacillus moniliformis. The symptoms of the streptobacillary form include a rash, a fever and arthralgias. The spirillary form causes rash, relapsing fever and regional lymphadenitis. Diagnosis is clinical and confirmed by culture and at times rising antibody titers. RBF is treated with doxycycline or penicillin. (Source: Disabled World)
Source: Disabled World - June 10, 2015 Category: Disability Tags: Health and Disability Source Type: news
Mayo Clinic News Network Headline 6/8/15
In today's Mayo Clinic News Network Headline with Vivien Williams: Swallowing medication without water or not properly following instructions when taking your pills may lead to a painful condition called drug-induced esophagitis. Antibiotics, such as tetracycline and doxycycline, have been linked to this condition. Mayo Clinic gastroenterologist Dr. Karthik Ravi explains. Journalists: Video is available in the downloads. [TRT 1:06] Click here for the script. https://youtu.be/jr2equ50vzg (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 8, 2015 Category: Databases & Libraries Source Type: news
Good News and Bad News for Antibiotics
Every credible medical and health organization, including the American Medical Association, the U.S. Centers for Disease Control and Prevention (CDC), and the World Health Organization, has said if we don't significantly reduce antibiotic use in people and agriculture, we will soon live in a world where these drugs no longer work. This frightening prospect of unwinding nearly a century of progress against bacterial infections frames three recent announcements - one good, one mostly good and one bad.
Quite simply, overuse of antibiotics is killing us. All organisms have the capacity to evolve in the face of biological thre...
Source: Science - The Huffington Post - May 27, 2015 Category: Science Source Type: news
Vibramycin Intravenous (Doxycycline hyclate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 27, 2015 Category: Drugs & Pharmacology Source Type: news
